Transthyretin amyloid cardiomyopathy: a paradigm for advancing precision medicine

Gonzalez-Lopez, E., Maurer, M. S., & Garcia-Pavia, P. (2025). Transthyretin amyloid cardiomyopathy: a paradigm for advancing precision medicine. European Heart Journal. https://doi.org/10.1093/eurheartj/ehae811
Authors:
Esther Gonzalez-Lopez
Mathew S. Maurer
Pablo García‐Pavía
Affiliated Authors:
Mathew S. Maurer
Columbia Affiliation:
Subjects:
Molecular Mechanisms of Amyloidosis (OpenAlex Topic)
Role of Fibroblast Activation in Cancer Progression (OpenAlex Topic)
Hypereosinophilic Syndrome and Related Disorders (OpenAlex Topic)
Author Keywords:
amyloid
cardiac amyloidosis
heart failure
transthyretin
elink
Publication Type:
Article
Unique ID:
10.1093/eurheartj/ehae811
PMID:
39791537
DOI:
10.1093/eurheartj/ehae811
Journal:
European Heart Journal
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record

Record Created: